ÂÜÀòÂÒÂ×

Peter Lawætz Andersen is the Chief Scientific Advisor at the Novo Nordisk Foundation, where they previously served as Senior Vice President overseeing the Foundation's infectious disease strategy. With a strong background in vaccine research, they were formerly the Executive Vice President at the Center for Vaccine Research at Statens Serum Institut. Their work has significantly contributed to the understanding of antigens and immune mechanisms, particularly in developing vaccines for diseases such as tuberculosis and Chlamydia. Peter has authored over 400 scientific papers and holds more than 25 patents, marking their prominence in the field of immunology. They are recognized for their leadership in international research consortiums and have received multiple prestigious awards, including the Novo Nordisk Prize for lifetime scientific achievement.